US drugmaker Pfizer said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
Instead, with the two operating as separate bu

Pharmaceutical company AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer in a deal that could be valued at more than $1.5 billion.
AstraZeneca, which saw off a $120 billion takeover attempt by Pfizer

Pfizer, beating out numerous other bidders, said it agreed to buy US cancer drug company Medivation for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.
Medivati

Pfizer is in advanced talks to acquire US cancer drug company Medivation for close to $14 billion, as it seeks to boost its oncology portfolio, a person familiar with the matter said on Sunday.
Pfizer has so far prevailed in the a

Pfizer is in advanced talks to acquire US cancer drug company Medivation for close to $14 billion, as it seeks to boost its oncology portfolio, a person familiar with the matter said on Sunday.
Pfizer has so far prevailed in the a

Pfizer Inc said it had acquired privately held gene therapy developer Bamboo Therapeutics Inc in a deal worth up to $645 million to boost its presence in the treatment of rare diseases.
Research into gene therapy, which aims to in

Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest US drugmaker said on Friday.
"We are enforcing a distribution restriction for specific products that have been part of,